GCP
TMDX icon

GSA Capital Partners’s Transmedics TMDX Stock Holding History

GSA Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
2,745
+512
+23% +$66.8K 0.02% 1303
2025
Q4 		$272K Sell
2,233
-3,748
-63% -$470K 0.02% 1224
2025
Q3 		$671K Buy
+5,981
New +$700K 0.06% 655
2025
Q2 		– Sell
-6,425
Closed -$432K – 2148
2025
Q1 		$432K Sell
6,425
-1,273
-17% -$87.6K 0.04% 900
2024
Q4 		$480K Buy
+7,698
New +$717K 0.04% 930
2024
Q3 		– Sell
-7,969
Closed -$1.2M – 2009
2024
Q2 		$1.2M Buy
+7,969
New +$956K 0.08% 390
2022
Q1 		– Sell
-33,499
Closed -$642K – 1831
2021
Q4 		$642K Buy
+33,499
New +$840K 0.08% 440

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's TMDX Position: Q1 2026 in Review

GSA Capital Partners increased its Transmedics (TMDX) stake by 23% in Q1 2026, buying an estimated $66.8K and bringing the position to 2,745 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #1303.

GSA Capital Partners first reported a position in TMDX in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.2M in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • GSA Capital Partners held 2,745 shares of Transmedics worth $273K as of Q1 2026.
  • GSA Capital Partners bought 512 Transmedics shares in Q1 2026, an estimated $66.8K.
  • Transmedics made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1303 holding.
  • GSA Capital Partners first reported a position in Transmedics in Q4 2021 and has held it in 7 quarters since.
  • GSA Capital Partners's Transmedics position peaked at $1.2M in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.